PEN:NYSE
Penumbra Inc
317,12 $
arrow_upward
+0,22%(+0,69) 1D
8 հոկ, 09:55:26 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
316,61 $
High
317,22 $
Low
316,61 $
Mkt. cap
12,49 մլրդ
Avg. vol.
368,32 հզր
Volume
8,19 հզր
P/E ratio
77,89
52-wk high
362,41 $
52-wk low
221,26 $
EPS
4,07 $
Beta
0,70
Shares outstanding
39,39 մլն
No. of employees
5 հզր
Open
316,61 $
High
317,22 $
Low
316,61 $
Mkt. cap
12,49 մլրդ
Avg. vol.
368,32 հզր
Volume
8,19 հզր
P/E ratio
77,89
52-wk high
362,41 $
52-wk low
221,26 $
EPS
4,07 $
Beta
0,70
Shares outstanding
39,39 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
4 ժամ առաջ
Penumbra presented STORM-PE data while Penumbra stock trades at EUR 281.30
AD HOC NEWS
·
1 օր առաջ
Penumbra stock gets fresh STORM-PE data catalyst
AD HOC NEWS
·
2 օր առաջ
Penumbra stock reports 14.9 percent revenue growth as EPS misses
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc